NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/21/2025
Back to search
Official data from USPTO
NEOSPHERE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
10/22/2025
Trademark type
Word
Nice classes
42
Filing date
07/05/2022
Registration date
10/21/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2025
Last transaction
10/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
16
Owner location
Planegg, DE
Examiner
KLUWE,CHERYL D
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
NEOsphere Biotechnologies GmbH
Representatives
Leo M. Loughlin ROTHWELL, FIGG, ERNST & MANBECK, PC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Analysis in the field of molecular biology; Consultancy relating to pharmaceutical research and development; Consultancy in the field of pharmaceutical research; Pharmaceutical product evaluation; Biochemistry research services; Biochemical analysis; Biochemistry services in the nature of mass spectrometry based proteomics and proteomic data analysis; Biochemical research and analysis; Biological analysis; Biological research and development services; Biological research; Biological research and analysis; Biological researchclinical research and medical research; Biomedical research services; Biotechnological research relating to industry; Research relating to biotechnology; Computer programming in the medical field; Computer software programming services; Medical research laboratory services; Biological research laboratory services; Services for assessing the efficiency of pharmaceuticals being testing of pharmaceuticals; Biotechnology testing; Analysis of human serum for medical research; Analysis of human tissues for medical research; Conducting of scientific studies and research in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Development of pharmaceutical drug preparations and medicines; Development and creation of computer programmes for data processing; Computer software development for others; Development of data bases; Pharmaceutical products development; computer software development; Design and development of data processing programs; Research and development of vaccines and medicines; Research relating to molecular sciences; Research on the subject of pharmaceuticals; Research and development services in the field of immunology; Research and development in the pharmaceutical and biotechnology fields; Biochemical research and development; Research and development for the pharmaceutical industry; Research and development in the field of microorganisms and cells; Clinical research in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Medical and scientific researchconducting clinical trials for others; Laboratory research services relating to pharmaceuticals; Medical research; Medical research in the field of oncology; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Preparation of biological samples for research purposes; Preparation of biological samples for analysis in research laboratories; Preparation of biological samples for testing and analysis in research laboratories; Scientific and technological servicesscientific analysis in the field of targeted protein degradation and targeted protein stabilization and related data analysis; Scientific research in the field of drug discovery; Scientific research relating to biology; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific investigations for medical purposes
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/21/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/02/2025
PUBO
PUBLISHED FOR OPPOSITION
09/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/27/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/21/2025
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/20/2024
DOCK
ASSIGNED TO EXAMINER
08/30/2024
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
02/16/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/16/2023
GNSL
LETTER OF SUSPENSION E-MAILED
08/16/2023
CNSL
SUSPENSION LETTER WRITTEN
08/16/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/19/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/19/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/24/2023
GNRT
NON-FINAL ACTION E-MAILED
04/24/2023
CNRT
NON-FINAL ACTION WRITTEN
04/24/2023
DOCK
ASSIGNED TO EXAMINER
04/19/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/11/2022
ALIE
ASSIGNED TO LIE
10/11/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/31/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/25/2022
NWAP
NEW APPLICATION ENTERED
07/08/2022
Continuous trademark protection
Get notified about every new filing that threatens NEOSPHERE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.